Jagielski Dariusz, Jacków-Nowicka Jagoda, Hrymniak Bruno, Kulbacki Marek, Bladowska Joanna
Faculty of Medicine, Wrocław University of Science and Technology, 50-370 Wroclaw, Poland.
Department of Cardiology, Center for Heart Diseases, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland.
J Clin Med. 2025 Jun 20;14(13):4395. doi: 10.3390/jcm14134395.
The axillary and cephalic veins are commonly utilized for transvenous pacemaker lead access. They typically advance to the heart through the subclavian, brachiocephalic, and superior vena cava veins. Anatomical variations such as a persistent left superior vena cava (PLSVC) may pose a challenge, necessitating an alternative approach for lead placement. This anomaly can often be identified during venographic contrast imaging or by visualizing atypical venous courses during the procedure. Another challenge occurs when the venous pathway is tortuous. Careful monitoring during the procedure is crucial to ensure that the lead follows the intended path. If not, the lead may inadvertently enter a collateral, such as the inferior thyroid vein, which drains into the internal jugular or left brachiocephalic vein. Despite these deviations, the lead may eventually reach the heart, although via an unusual course. If such a lead is left in place, even in the absence of immediate complications, long-term outcomes are unpredictable and carry the risk of unforeseen complications.
腋静脉和头静脉通常用于经静脉起搏器导线置入。它们通常通过锁骨下静脉、头臂静脉和上腔静脉进入心脏。解剖变异,如永存左上腔静脉(PLSVC),可能带来挑战,需要采用替代方法进行导线放置。这种异常通常可以在静脉造影对比成像期间或在手术过程中观察到非典型静脉走行时被识别。当静脉通路迂曲时,会出现另一个挑战。手术过程中的仔细监测对于确保导线沿着预期路径至关重要。如果不是这样,导线可能会无意中进入侧支血管,如下甲状腺静脉,它汇入颈内静脉或左头臂静脉。尽管有这些偏差,导线最终可能会到达心脏,尽管路径不寻常。如果将这样的导线留在原位,即使没有立即出现并发症,长期结果也不可预测,并且存在不可预见并发症的风险。